lobbying_activities: 2815834

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2815834	0c7d5dc2-e973-400d-a441-badb48a64652	Q2	HOLLAND & KNIGHT LLP	18466	ALLIANCE FOR REGENERATIVE MEDICINE	2022	second_quarter	MMM	Value Based Payment legislation; Cures 2.0 legislation; CMS policies regarding Value Based legislation; FDA user fee legislation; H.R. 7667, Food and Drug Amendments of 2022; S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act.	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2022-07-08T16:39:44-04:00